Document is current
Any future updates will be listed below
-
Authors
Kim, Hoon https://orcid.org/0000-0003-4244-6126
Kim, Soyeon https://orcid.org/0009-0004-6509-5490
Wade, Taylor
Yeo, Eunchae
Lipsa, Anuja https://orcid.org/0000-0002-9668-6048
Golebiewska, Anna https://orcid.org/0000-0002-4160-2521
Johnson, Kevin C. https://orcid.org/0000-0003-0016-5158
An, Sepil https://orcid.org/0009-0008-6293-5473
Ko, Junyong
Nam, Yoonjoo
Lee, Hwa Yeon
Kang, Seunghyun https://orcid.org/0009-0002-6481-310X
Chung, Heesuk
Niclou, Simone P.
Moon, Hyo-Eun
Paek, Sun Ha https://orcid.org/0000-0003-3007-8653
Bafna, Vineet
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Verhaak, Roel G. W. https://orcid.org/0000-0003-2773-0436
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 13 September 2024
First Online: 14 October 2024
Competing interests
: R.G.W.V. is a cofounder of, holds equity in and has received research funds from Boundless Bio. H.K. has received research funds from JW Pharmaceutical. J.L. receives compensation as a part-time consultant for Boundless Bio. V.B. is a cofounder, paid consultant and Scientific Advisory Board member, and has an equity interest in Boundless Bio and Abterra. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. All other authors declare no competing interests.
